Li, Y.; Kong, X.; Chu, X.; Fu, H.; Feng, X.; Zhao, C.; Deng, Y.; Ge, J.
Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents. Molecules 2024, 29, 2836.
https://doi.org/10.3390/molecules29122836
AMA Style
Li Y, Kong X, Chu X, Fu H, Feng X, Zhao C, Deng Y, Ge J.
Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents. Molecules. 2024; 29(12):2836.
https://doi.org/10.3390/molecules29122836
Chicago/Turabian Style
Li, Yingpeng, Xianxiu Kong, Xinhong Chu, Hui Fu, Xinchi Feng, Chengcheng Zhao, Yanru Deng, and Jun Ge.
2024. "Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents" Molecules 29, no. 12: 2836.
https://doi.org/10.3390/molecules29122836
APA Style
Li, Y., Kong, X., Chu, X., Fu, H., Feng, X., Zhao, C., Deng, Y., & Ge, J.
(2024). Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents. Molecules, 29(12), 2836.
https://doi.org/10.3390/molecules29122836